Emerging Drugs and Indications for Cardio-Metabolic Disorders in People with Severe Mental Illness

E-ISSN： 1873-4286|21|23|3317-3324

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.23, 2015-01, pp. : 3317-3324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 19, 2016-08 ,pp. : 2189-2200

Bentham Science Publishers

Access to resources Recommend Favorite

Repurposed Drugs in Metabolic Disorders

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 18, 2013-09 ,pp. : 2386-2394

Bentham Science Publishers

Access to resources Recommend Favorite

Enabling healthy living: Experiences of people with severe mental illness in psychiatric outpatient services

INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, Vol. 27, Iss. 1, 2018-02 ,pp. : 236-246

John Wiley & Sons Inc

Access to resources Recommend Favorite

Emerging drugs for moderate-to-severe psoriasis

By Magliocco Melissa A

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 35-52

Informa Healthcare

Access to resources Recommend Favorite

Hormonal Regulation of Nitric Oxide (NO) in Cardio-metabolic Diseases

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1427-1434

Bentham Science Publishers

Access to resources Recommend Favorite